Abstract
Tumour cell invasiveness is crucial for cancer metastasis and is not yet understood. Here we describe two functional screens for proteins required for the invasion of fibrosarcoma cells that identified the molecular chaperone heat shock protein 90 (hsp90). The hsp90α isoform, but not hsp90β, is expressed extracellularly where it interacts with the matrix metalloproteinase 2 (MMP2). Inhibition of extracellular hsp90α decreases both MMP2 activity and invasiveness. This role for extracellular hsp90α in MMP2 activation indicates that cell-impermeant anti-hsp90 drugs might decrease invasiveness without the concerns inherent in inhibiting intracellular hsp90.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
BMC Complementary Medicine and Therapies Open Access 09 January 2023
-
Vascular endothelium deploys caveolin-1 to regulate oligodendrogenesis after chronic cerebral ischemia in mice
Nature Communications Open Access 10 November 2022
-
MicroRNA-570 targets the HSP chaperone network, increases proteotoxic stress and inhibits mammary tumor cell migration
Scientific Reports Open Access 16 September 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout






References
Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000).
Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000).
Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003).
Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536–540 (2000).
Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
MacDonald, T.J. et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nature Genet. 29, 143–152 (2001).
Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431–437 (2004).
Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627–637 (2003).
Beck, S. et al. Fluorophore-assisted light inactivation: A high-throughput tool for direct target validation of proteins. Proteomics 2, 247–255 (2002).
Hoogenboom, H.R. et al. Antibody phage display technology and its applications. Immunotechnology 4, 1–20 (1998).
Harlow, E. & Lane, D. Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988).
Kinter, M. & Sherman, N.E. Protein Sequencing and Identification using Tandem Mass Spectrometry (Wiley-Interscience, New York, 2000).
Rust, W.L., Carper, S.W. & Plopper, G.E. The promise of integrins as effective targets for anticancer agents. J. Biomed. Biotechnol. 2, 124–130 (2002).
Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z. & Nardai, G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 79, 129–168 (1998).
Richter, K. & Buchner, J. Hsp90: chaperoning signal transduction. J. Cell. Physiol. 188, 281–290 (2001).
Hanwell, D., Ishikawa, T., Saleki, R. & Rotin, D. Trafficking and cell surface stability of the epithelial Na+ channel expressed in epithelial Madin–Darby canine kidney cells. J. Biol. Chem. 277, 9772–9779 (2002).
Honda, K. et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol. 140, 1383–1393 (1998).
Liao, D.F. et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J. Biol. Chem. 275, 189–196 (2000).
Schafer, T. et al. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279, 6244–6251 (2004).
Wubbolts, R.W. et al. Proteomic and biochemical analyses of human B cell-derived exosomes: potential implications for their function and multivesicular body formation. J. Biol. Chem. 278, 10963–10972 (2003).
Thery, C. et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166, 7309–7318 (2001).
Albertini, S. et al. Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 10, 343–351 (1995).
Young, J.C., Moarefi, I. & Hartl, F.U. Hsp90: a specialized but essential protein-folding tool. J. Cell Biol. 154, 267–273 (2001).
Xu, Y. & Lindquist, S. Heat-shock protein hsp90 governs the activity of pp60v-src kinase. Proc. Natl Acad. Sci. USA 90, 7074–7078 (1993).
Xu, Y., Singer, M.A. & Lindquist, S. Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proc. Natl Acad. Sci. USA 96, 109–114 (1999).
Pratt, W.B. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268, 21455–21458 (1993).
Ferrarini, M., Heltai, S., Zocchi, M.R. & Rugarli, C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 51, 613–619 (1992).
Triantafilou, K., Triantafilou, M. & Dedrick, R.L. A CD14-independent LPS receptor cluster. Nature Immunol. 2, 338–345 (2001).
Liotta, L.A. et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67–68 (1980).
Lopez-Otin, C. & Overall, C.M. Protease degradomics: a new challenge for proteomics. Nature Rev. Mol. Cell Biol. 3, 509–519 (2002).
Lehti, K., Lohi, J., Valtanen, H. & Keski-Oja, J. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J. 334, 345–353 (1998).
Sternlicht, M.D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463–516 (2001).
Pearl, L.H. & Prodromou, C. Structure and in vivo function of Hsp90. Curr. Opin. Struct. Biol. 10, 46–51 (2000).
Whitesell, L., Mimnaugh, E.G., De Costa, B., Myers, C.E. & Neckers, L.M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl Acad. Sci. USA 91, 8324–8328 (1994).
Basso, A.D. et al. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 277, 39858–39866 (2002).
Schulte, T.W., Blagosklonny, M.V., Ingui, C. & Neckers, L. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J. Biol. Chem. 270, 24585–24588 (1995).
Neckers, L. & Ivy, S.P. Heat shock protein 90. Curr. Opin. Oncol. 15, 419–424 (2003).
Yufu, Y., Nishimura, J. & Nawata, H. High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leuk. Res. 16, 597–605 (1992).
Lebeau, J., Le Chalony, C., Prosperi, M.T. & Goubin, G. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene. Oncogene 6, 1125–1132 (1991).
Gress, T.M. et al. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res. 54, 547–551 (1994).
Kamal, A. et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425, 407–410 (2003).
Traut, T.W. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1–22 (1994).
Basu, S., Binder, R.J., Ramalingam, T. & Srivastava, P.K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303–313 (2001).
Overall, C.M. & Lopez-Otin, C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nature Rev. Cancer 2, 657–672 (2002).
Harlow, E. & Lane, D. Using Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1999).
Acknowledgements
We thank M. Berne for performing the mass spectrometry analysis on 1.5.1 immunoprecipitates, and J. Dice, J. Kerner and K. Sloan for critical reading of the manuscript. This work was supported in part by grants from the National Cancer Institute (to D.G.J.), a National Institutes of Health Training grant (B.K.E.) and a National Institutes of Health Program grant to the Gastroenterology Research on Absorptive and Secretory Processes group (GRASP).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.U., C.Z., B. L., C.T., S.W.H., G.B., L.L.I. and D.G.J. received funding (research support and salaries) from Xerion Pharmaceuticals.
Supplementary information
Supplementary Figures
Supplementary Fig. S1, S2 and S3 (PDF 341 kb)
Rights and permissions
About this article
Cite this article
Eustace, B., Sakurai, T., Stewart, J. et al. Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness. Nat Cell Biol 6, 507–514 (2004). https://doi.org/10.1038/ncb1131
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb1131
This article is cited by
-
Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study
BMC Complementary Medicine and Therapies (2023)
-
DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer
BMC Cancer (2022)
-
Vascular endothelium deploys caveolin-1 to regulate oligodendrogenesis after chronic cerebral ischemia in mice
Nature Communications (2022)
-
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
Oncogene (2022)
-
MicroRNA-570 targets the HSP chaperone network, increases proteotoxic stress and inhibits mammary tumor cell migration
Scientific Reports (2022)